Mobia Medical Inc. Common Stock (MOBI)
Stock · NASDAQ · Health Care
$8.08as of 10/16/2026
Price chart
Active signals
About MOBI
Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable device designed to aid in…
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Employees
- 167
- Website
- www.mobia.com
Fundamentals
- 1-day range
- $8.25$8.42
- Market cap
- $409.63M
- P/E (trailing)
- —
- P/E (forward)
- -3.77
- EPS (trailing)
- —
- Dividend yield
- —
- Beta
- 1.39
- Avg. volume
- 178.9K
Forecasts
4 analyst ratings
Mobia Medical Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- MOBIMobia Medical Inc. Common Stock$8.09▼ 2.65%Market cap $409.63MP/E —$8.16$15.29
- CLPTClearPoint Neuro Inc. Common Stock$9.07▼ 5.91%Market cap $408.45MP/E —$8.27$28.1
- OFIXOrthofix Medical Inc. Common Stock (DE)$9.38▼ 2.19%Market cap $428.47MP/E —$8.5$16.99
- SGHTSight Sciences Inc. Common Stock$8.28▼ 5.91%Market cap $385.77MP/E —$3.34$9.71
- CARLCarlsmed Inc. Common Stock$13.41▼ 3.87%Market cap $372.43MP/E —$8.5$17.23
- SIShoulder Innovations Inc. Common Stock$18.09▼ 1.52%Market cap $465.16MP/E —$10.92$24.6
- CERSCerus Corporation Common Stock$2.18▼ 3.54%Market cap $467.54MP/E —$1.38$3.47
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| MOBI Mobia Medical Inc. Common Stock | $409.63M | — | $8.09 | ▼ 2.65% | $8.16$15.29 |
| CLPT ClearPoint Neuro Inc. Common Stock | $408.45M | — | $9.07 | ▼ 5.91% | $8.27$28.1 |
| OFIX Orthofix Medical Inc. Common Stock (DE) | $428.47M | — | $9.38 | ▼ 2.19% | $8.5$16.99 |
| SGHT Sight Sciences Inc. Common Stock | $385.77M | — | $8.28 | ▼ 5.91% | $3.34$9.71 |
| CARL Carlsmed Inc. Common Stock | $372.43M | — | $13.41 | ▼ 3.87% | $8.5$17.23 |
| SI Shoulder Innovations Inc. Common Stock | $465.16M | — | $18.09 | ▼ 1.52% | $10.92$24.6 |
| CERS Cerus Corporation Common Stock | $467.54M | — | $2.18 | ▼ 3.54% | $1.38$3.47 |
P/E shows — for peers not currently carrying a live signal of their own.
Insider Activity
Insider Actions →- Chase C. Leavitt · September 11, 2026 · Buy2.0K @ $10.3
- Prashant B. Rawat · September 2, 2026 · Option Exercise15.0K @ $3.38
- Casey M. Tansey · August 18, 2026 · Buy16.4K @ $12.07
- Casey M. Tansey · August 17, 2026 · Buy17.2K @ $11.85
- Casey M. Tansey · August 14, 2026 · Buy100 @ $12.53
- Casey M. Tansey · August 14, 2026 · Buy15.7K @ $11.65
- Casey M. Tansey · August 13, 2026 · Buy35.6K @ $11.51
- Myriam Curet · July 30, 2026 · Grant16.0K
- Myriam Curet · July 30, 2026 · Grant19.7K
- Zadno Reza · July 14, 2026 · Grant16.3K
- Zadno Reza · July 14, 2026 · Grant19.1K
- Prashant B. Rawat · June 10, 2026 · Option Exercise15.0K @ $3.38
- Nelson Bunker Curnes · June 9, 2026 · Buy5.0K @ $12.79
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Mobia Medical Announces Q3 2026 Earnings Release Date
Mobia Medical Inc. has set November 5, 2026 as the date to release its third‑quarter 2026 financial results. The announcement comes as the company prepares to share its latest performance data. Investors will be able to see how the company’s operations and revenue compare to expectations. The disclosure follows the company’s recent trading near its 52‑week range.
Mobia Medical Announces Q3 2026 Earnings Release Date. Mobia Medical Inc. has set November 5, 2026 as the date to release its third‑quarter 2026 financial results. The announcement comes as the company prepares to share its latest performance data. Investors will be able to see how the company’s operations and revenue compare to expectations. The disclosure follows the company’s recent trading near its 52‑week range.